|
DHFRL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34070540727771E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35379493673804E-11 |
| Normal-vs-Stage2 |
3.1612999995545E-07 |
| Normal-vs-Stage3 |
1.7586000433667E-09 |
| Normal-vs-Stage4 |
8.16330003594601E-09 |
| Stage1-vs-Stage2 |
8.876400E-01 |
| Stage1-vs-Stage3 |
3.312400E-01 |
| Stage1-vs-Stage4 |
1.412030E-01 |
| Stage2-vs-Stage3 |
4.900800E-01 |
| Stage2-vs-Stage4 |
1.423790E-01 |
| Stage3-vs-Stage4 |
3.423400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.45959960468667E-11 |
| Normal-vs-AfricanAmerican |
3.51463302905586E-12 |
| Normal-vs-Asian |
4.95349999996009E-06 |
| Caucasian-vs-AfricanAmerican |
7.721500E-02 |
| Caucasian-vs-Asian |
3.648200E-01 |
| AfricanAmerican-vs-Asian |
5.768200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.88547005470264E-12 |
| Normal-vs-Female |
1.75740000329938E-08 |
| Male-vs-Female |
3.064400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.38610012356821E-10 |
| Normal-vs-Extreme_Weight |
1.64501745558709E-12 |
| Normal-vs-Obese |
4.44140002553439E-09 |
| Normal-vs-Extreme_Obese |
1.960090E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.658200E-01 |
| Normal_Weight-vs-Obese |
2.685800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.901050E-01 |
| Extreme_Weight-vs-Obese |
2.383200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.345600E-01 |
| Obese-vs-Extreme_Obese |
5.753600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98619999838934E-08 |
| Normal-vs-Age(41-60Yrs) |
1.65989999523219E-08 |
| Normal-vs-Age(61-80Yrs) |
3.04511971194188E-12 |
| Normal-vs-Age(81-100Yrs) |
5.03189999667697E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.540000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.690400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.816600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.314000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.889800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.563400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51889945065875E-10 |
| Normal-VS-Type2 PRCC |
1.80266912508387E-12 |
| Normal-VS-KIRP CIMP |
1.17080000139325E-08 |
| Normal-VS-Unclassified PRCC |
8.279700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.753700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.479000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.224200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.711800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.072500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.459670E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46900269726302E-11 |
| Normal-vs-N1 |
3.74910003042572E-09 |
| Normal-vs-N2 |
7.2326000000178E-07 |
| N0-vs-N1 |
4.460600E-01 |
| N0-vs-N2 |
2.060200E-01 |
| N1-vs-N2 |
5.311500E-02 |
|
|
